COMPOSITION FOR THE TREATMENT AND PREVENTION OF PEPTIC ULCER
Filed: December 19th, 2006 [Pending]
Patent Application Number: 11612549
... mg/ml ml/k£ mg/kg rats PO with MIC analogues 2 1 Vehicle PO (2% Tween80) 10 NA 5 30 mins Before challenge 2 Carbenoxolone PO 30 mg/ml 10 300 mg/kg 5 30 ...
Uses for amino acid anticonvulsants
Filed: August 24th, 2001 [Granted]
Patent Number: 6884910
35 EXAMPLE 2 Test substance was administered (30 or 100 mg/kg) to groups of ... I PO 100 mg/kg 2 0 Compound I PO 100 mg/kg 3 0 100 Compound I PO 30 mg/kg 1 ...
NEW USES FOR AMINO ACID ANTICONVULSANTS
Filed: July 1st, 2010 [Pending]
Patent Application Number: 12829160
Example 4 [0287] Test substance was administered PO (30 mg/kg) to a group of 3 Long Evans derived male or female rats weighing 150±20 gms one hour before ...
Users for amino acid anticonvulsants
Filed: October 17th, 2003 [Pending]
Patent Application Number: 10688709
EXAMPLE 1 [0296] Test substance was administered PO (30 or 100 mg/kg) to groups of 3 ICR derived male or female mice weighing 22±2 gms one hour before ...
6-substituted furo-(3,4-c)-pyridine derivatives and anti-depressant ...
Filed: January 23rd, 1985 [Granted]
Patent Number: 4581362
IP administration of haloperidol at 5 mg/kg induces catalepsy. ... 60 mg/kg PO 60%) Yohimbine HC1 30 mg/kg SC 20% Ex. 5 10 mg/kg PO 60% 30 mg/kg PO 60% ...
Formulations for hydrophobic pharmaceutical agents
Filed: March 4th, 1998 [Granted]
Patent Number: 6248771
Dosage Route Dosage (mg/kg) Dog Group Formulation Cone (mg/mL) 1 698-99 898-25 ... 898-27 Oral(PO) 12.5 mg/kg 3 7.58 mg/mL 698-99 980-3 Oral(PO) 30 mg/mL ...
Methods and compositions for treating and preventing anxiety and anxiety ...
Filed: October 27th, 1999 [Granted]
Patent Number: 6080736
Based on those assays, test substances were administered orally to the rats one hour before interperitoneal injection of 3 mg/kg 5-MeODMT.
Use of GAL3 receptor antagonists for the treatment of depression and/or ...
Filed: January 31st, 2002 [Pending]
Patent Application Number: 10066175
In contrast, a single po administration of 10 or 30 mg/kg of Example 22 produced a significant increase in swimming and a significant decrease in immobility ...